Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Randomized Study of Classic vs Simplified Leucovorin Calcium and Fluorouracil With or Without Irinotecan in Patients Aged At Least 75 Years With Advanced Colorectal Cancer
5 other identifiers
interventional
282
1 country
77
Brief Summary
RATIONALE: Drugs used in chemotherapy, such as fluorouracil, leucovorin, and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) in different doses or combinations may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective in treating colorectal cancer. PURPOSE: This randomized clinical trial is studying how well fluorouracil works together with leucovorin with or without irinotecan in treating older patients with metastatic colorectal cancer .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 colorectal-cancer
Started Jun 2003
Typical duration for phase_3 colorectal-cancer
77 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2003
CompletedFirst Submitted
Initial submission to the registry
March 15, 2006
CompletedFirst Posted
Study publicly available on registry
March 17, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedMay 30, 2016
May 1, 2016
7.6 years
March 15, 2006
May 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Progression Free Survival (survie sans progression)
survie sans progression
2011
Secondary Outcomes (1)
Overall Survival (survie globale)
2011
Study Arms (4)
LV5FU2 classique
ACTIVE COMPARATORLV5FU2 classique
LV5FU2 classique + irinotécan
EXPERIMENTALLV5FU2 classique + irinotécan
LV5FU2 simplifié
ACTIVE COMPARATORLV5FU2 simplifié
LV5FU2 simplifié+ irinotécan
EXPERIMENTALLV5FU2 simplifié + irinotécan
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (77)
Centre Hospitalier d'Abbeville
Abbeville, 80101, France
Centre Hospitalier D'Agen
Agen, 47923, France
Centre hospitalier d'Alencon
Alençon, 61000, France
Clinique De Rochebelle
Alès, F-30100, France
Centre Hospitalier Universitaire d'Amiens
Amiens, 80054, France
Centre Hospitalier d'Annecy
Annecy, 74011 Cedex, France
Institut Sainte Catherine
Avignon, 84000, France
Hopital Duffaut
Avignon, 84902, France
Centre Hospitalier de Blois
Blois, 41016, France
Hopital Saint Andre
Bordeaux, 33075, France
Hopital Ambroise Pare
Boulogne-Billancourt, F-92104, France
Centre Hospitalier Docteur Duchenne
Boulogne-sur-Mer, 62200, France
C.H. Bourg En Bresse
Bourg-en-Bresse, 01012, France
Centre Hospitalier Pierre Oudot
Bourgoin, 38300, France
Centre Hospitalier de Briey
Briey, 54151, France
Centre Medical de Bligny
Briis-sous-Forges, 91640, France
Centre hospitalier de Charleville Mezieres
Charleville-Mézières, 08000, France
Centre Hospitalier de Chalons-en-Champagne
Châlons-en-Champagne, 51000, France
Centre Hospitalier de Chateaubriant
Châteaubriant, 44146, France
Hopital Louis Pasteur
Colmar, 68024, France
Louis Mourier Hospital
Colombes, 92701, France
Centre Hospitalier Universitaire Henri Mondor
Créteil, 94000, France
Centre Hospitalier de Digne les Bains
Digne-les-Bains, 04003, France
Hopital Du Bocage
Dijon, 21034, France
Centre Hospitalier de Dreux
Dreux, 28100, France
Centre Hospitalier Intercommunal St. Aubin les Elbeuf
Elbeuf, 76503, France
Clinique Saint Vincent
Épernay, 51200, France
CHU de Grenoble - Hopital Michallon
Grenoble, 38043, France
Clinique Pasteur
Guilherand-Granges, 07500, France
Centre Hospitalier de Haguenau
Haguenau, 67504, France
Centre Hospitalier Departemental
La Roche-sur-Yon, F-85025, France
Centre Hospitalier Universitaire de Bicetre
Le Kremlin-Bicêtre, 94275, France
Hopital Perpetuel Secours
Levallois-Perret, 92309, France
Hopital Robert Boulin
Libourne, 33500, France
Centre Hospital Universitaire Hop Huriez
Lille, 59037, France
Centre Hospital Regional Universitaire de Limoges
Limoges, 87042, France
Centre Hospitalier General
Longjumeau, 91164, France
Clinique Saint Jean
Lyon, 69008, France
Hopital Edouard Herriot - Lyon
Lyon, 69437, France
CHU de la Timone
Marseille, 13385, France
CHU Nord
Marseille, 13915, France
Centre Hospitalier de Martigues
Martigues, 13698, France
Centre Gray
Maubeuge, 59600, France
Centre Hospitalier de Meaux
Meaux, 77104, France
Centre Hospitalier General de Mont de Marsan
Mont-de-Marsan, 40000, France
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Montpellier, 34298, France
CHU de Nancy - Hopitaux de Brabois
Nancy, 54035, France
Centre Hospitalier de Nevers
Nevers, 58033, France
Hopital de l'Archet CHU de Nice
Nice, F-06202, France
C.H.U. de Nimes - Groupe Hospitals-Universitaire Caremeau
Nîmes, 30029, France
Centre Hospitalier d'Orange
Orange, 84100, France
Hopital d'Instruction des Armees du Val de Grace
Paris, 75005, France
Hopital Europeen Georges Pompidou
Paris, 75015, France
Hopital Bichat - Claude Bernard
Paris, 75018, France
CHU Pitie-Salpetriere
Paris, 75651, France
Hopital Cochin
Paris, 75674, France
Hopital Tenon
Paris, 75970, France
Centre Hospitalier - Pau
Pau, 64046, France
Centre Hospitalier de Perpignan
Perpignan, 66046, France
Hopital Haut Leveque
Pessac, 33604, France
Hopital Rene Dubos
Pontoise, 95300, France
CHU - Robert Debre
Reims, 51092, France
Polyclinique De Courlancy
Reims, F-51100, France
Centre Eugene Marquis
Rennes, 35064, France
Centre Hospitalier Universitaire de Rouen
Rouen, 76031, France
Pole Sante Sarthe et Loir Hopital Pierre Daguet
Sablé-sur-Sarthe, 72305, France
Centre Rene Huguenin
Saint-Cloud, 92210, France
Hopital d'Instruction des Armees Begin
Saint-Mandé, 94160, France
Centre Hospitalier de Saint-Quentin
Saint-Quentin, 02321, France
Center Hospitalier de Sens
Sens, 89108, France
Hopital Foch
Suresnes, 92151, France
Centre Hospitalier Valence
Valence, 26000, France
Nouvelle Clinique Generale
Valence, 26000, France
Centre Hospitalier de Valenciennes
Valenciennes, 59322, France
Centre Hospitalier Intercommunal de la Haute-Saone
Vesoul, 70000, France
Institut Gustave Roussy
Villejuif, F-94805, France
Centre Hospitalier de Vire
Vire, 14504, France
Related Publications (4)
Aparicio T, Jouve J, Teillet L, et al.: Geriatric factors to predict toxicity and dose-intensity reduction in FFCD 2001-02 phase III study comparing a first-line chemotherapy of LV5FU2 or FOLFIRI in treatment of metastatic colorectal cancer (mCRC) in elderly patients. [Abstract] J Clin Oncol 29 (Suppl 15): A-9111, 2011.
RESULTMitry E, Phelip JM, Bonnetain F, et al.: Phase III trial of chemotherapy with or without irinotecan in the front-line treatment of metastatic colorectal cancer in elderly patients (FFCD 2001-02 trial): results of a planned interim analysis. [Abstract] American Society of Clinical Oncology 2008 Gastrointestinal Cancers Symposium, 25-27 January 2008, Orlando, FL. A-281, 2008.
RESULTAparicio T, Lavau-Denes S, Phelip JM, Maillard E, Jouve JL, Gargot D, Gasmi M, Locher C, Adhoute X, Michel P, Khemissa F, Lecomte T, Provencal J, Breysacher G, Legoux JL, Lepere C, Charneau J, Cretin J, Chone L, Azzedine A, Bouche O, Sobhani I, Bedenne L, Mitry E; FFCD investigators. Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02). Ann Oncol. 2016 Jan;27(1):121-7. doi: 10.1093/annonc/mdv491. Epub 2015 Oct 20.
PMID: 26487578RESULTAparicio T, Jouve JL, Teillet L, Gargot D, Subtil F, Le Brun-Ly V, Cretin J, Locher C, Bouche O, Breysacher G, Charneau J, Seitz JF, Gasmi M, Stefani L, Ramdani M, Lecomte T, Mitry E. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients. J Clin Oncol. 2013 Apr 10;31(11):1464-70. doi: 10.1200/JCO.2012.42.9894. Epub 2013 Mar 4.
PMID: 23460711RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Emmanuel Mitry, MD, PhD
Hopital Ambroise Pare
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 15, 2006
First Posted
March 17, 2006
Study Start
June 1, 2003
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
May 30, 2016
Record last verified: 2016-05